The FDA’s expert panel on vaccines voted Thursday to recommend that anyone who gets a primary Covid vaccine going forward ...

The expert panel agreed it was time to use the same strain in both the primary and booster doses of the COVID-19 vaccine ...

A panel of independent experts that advises the Food and Drug Administration on vaccines has backed a proposal to use the ...

Dr. Kristin Moffitt, an infectious disease specialist at Boston Children's Hospital talks about concerns about COVID vaccines ...

Currently, Pfizer's and Moderna's omicron shots are authorized as a booster, while the first two doses are still the old shots based on the original strain.

In a document posted ahead of an advisory group meeting on Jan 26, the US Food and Drug Administration (FDA) today spelled ...

At a meeting of this FDA ... Covid-19 and who did not. It found that 1.9% of the study participants who received the original booster became infected. Among those who got the updated bivalent ...

Protecting against Covid infection with the current mRNA technology is unrealistic, a vaccine expert said in a paper ...

The FDA’s Vaccines and Related Biological Products Advisory Committee (VRBPAC) will meet Thursday to discuss how to simplify ...

In November 2019, a bat coronavirus ... doses of Moderna’s bivalent vaccine, intending to offer both vaccines in the fall and winter. On September 1, 2022, the FDA withdrew its emergency use ...

Moderna and the Food and Drug Association (FDA) have been accused of concealing data during the approval process for the pharma giant's bivalent Covid booster. Vaccine advisors who signed off on ...

As reported by the FDA, a bivalent vaccine was developed to provide better protection against the omicron variant, and can be referred to as an updated COVID-19 vaccine booster dose. The real ...